BackTriSalus Life Sciences Overview

TriSalus Life Sciences Profit Margin

Valuation check: TLSI's profit margin is -130.17%, below the sector sector average of 22.52%.

Get informed when a big investor buys or sells

+ Follow

Quarterly Profit Margin

-80.54%
8.96% YoY

As of Jun 2026

Annual Profit Margin (TTM)

-130.17%
43.33% YoY

Trailing 12 months ending Jun 2026

Average Profit Margin (Comparison Companies)

Loading

Profit Margin History

Loading

Profit Margin Comparison

Loading

Annual Profit Margin Growth Rate (%)

Loading

TriSalus Life Sciences (TLSI) FAQ

As of the most recent data (June 2026), TLSI shows a profit margin of -130.17%. That compares with -90.82% in the prior-year period — down 43.3% year over year. That is below the sector sector average of 22.52%. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, TLSI's profit margin is now -130.17% (was -90.82%) — a 43.3% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether TriSalus Life Sciences is outperforming or lagging.

The its sector sector average profit margin is about 22.52%. TriSalus Life Sciences is at -130.17%, which is lower that average. That is roughly 678.0% below the sector mean. Use the comparison chart on this page to see how TLSI stacks up against individual peers as well.

That compares with -90.82% in the prior-year period — down 43.3% year over year. Improvement over multiple periods is generally more meaningful than a single strong quarter. Compare TriSalus Life Sciences with peers to see if the move is company-specific or sector-wide.

Besides this profit margin page, Stockcircle has TriSalus Life Sciences's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect profit margin (currently -130.17%) with ownership activity and broader fundamentals.